IQ150®

World’s Alzheimer’s Cases to Quadruple by 2050

1 in 85 people expected to have disease in 40 years, researchers predict

Associated Press

WASHINGTON – More than 26 million people worldwide have Alzheimer’s disease, and a new forecast says the number will quadruple by 2050.

At that rate, one in 85 people will have the brain destroying disease in 40 years, researchers from Johns Hopkins University conclude.

The new estimates, being presented Sunday at an Alzheimer’s Association conference in Washington, are not very different from previous projections of the looming global dementia epidemic with the graying of the world’s population. But they serve as a sobering reminder of the toll to come if scientists cannot find better ways to battle Alzheimer’s and protect aging brains.

“If we can make even modest advances in preventing Alzheimer’s disease, or delay its progression, we could have a huge global public health impact,” said Johns Hopkins public health specialist Ron Brookmeyer, who led the new study.

The biggest jump is projected for densely populated Asia, home of almost half of today’ s Alzheimer’s cases, 12.6 million. By 2050, Asia will have 62.8 million of the world’s 106 million Alzheimer’s patients, the study projects

Citicoline (Cognizin®)
provides vital nutrients that help the brain generate electrical impulses, care for healthy brain cells, and protect neurons from free radical damage. Numerous scientific studies have shown that Citicoline has a measurable effect on memory for healthy individuals as well improving mild memory problems associated with aging.

Baccopa Monnieri
supports healthy brain functioning, promotes relaxation of mind and concentration. It helps to enhance intellect and consciousness, increases protein synthesis and activity in brain cells. It improves memory, decreases anxiety, restlessness and senility. It helps in cases of insomnia (sleeplessness) and confused and cloudy thoughts.

Turmeric Root Powder
also known as Curcumin, is derived from the root of the Curcumin plant. It has recently been shown to be effective in enhancing neuro transmitters and has antioxidant and neuro-stimulatory effects.

Spanish Sage
is an extract of the leaf of the Spanish Sage plant Salvia lavandulaefolia, which was demonstrated in recent studies to enhance memory in adults. It was known for years by our ancestors that it had this kind of effect which has recently been confirmed in clinical studies at European universities.

Green Tea
is derived from the leaf, leaf bud and stem of the common tea plant Camellia sinensis. It has powerful antioxidant polyphenols, flavonoids and phenolic acids as well as caffeine, all of which act to protect the brain and improve alertness, clarity and retention.

Caffeine (from Coffee Beans)
restores alertness when drowsiness occurs. It produces increased wakefulness, faster and clearer flow of thought, increased focus, and better general body coordination.

Ginkgo Biloba
is widely used in Europe for treating dementia. Its use is primarily due to its ability to improve blood flow to the brain and because of its antioxidant properties. Ginkgo may improve thinking, learning, and memory in people with Alzheimer’s disease (AD).

Phosphatidylserine
otherwise known as PS, has been used for age-related decline in mental function in older people as well as improving quality of function in younger people. Additionally, it has been used in the treatment of attention deficit, hyperactivity disorder and depression.

Phosphatidylcholine
has been shown to increase acetyl-choline, norepinephrine, serotonin and dopamine levels in both animal models and patients with Alzheimer’s disease. Phosphatidylcholine is another brain protector and in clinical trials has been shown to improve explicit memory.